Inverness Medical Innovations has acquired Biosite

Covington Associates LLC has advised Inverness Medical Innovations, Inc. (AMEX: IMA), a leading global developer of advanced diagnostic devices and proprietary electrochemical and other technologies in a variety of professional diagnostic and consumer-oriented applications including immuno-diagnostics with a focus on women's health, cardiology and infectious disease on its $1.8 billion acquisition of Biosite, Inc. (NASDAQ:  BSTE), a leading provider of rapid diagnostics products and antibody development technologies.